blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4061428

EP4061428 - PH RESPONSIVE COMPOSITIONS, FORMULATIONS, AND METHODS OF IMAGING A TUMOR [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  26.08.2022
Database last updated on 14.09.2024
FormerThe international publication has been made
Status updated on  29.05.2021
Most recent event   Tooltip08.06.2024Amendment by applicant 
Applicant(s)For all designated states
Onconano Medicine, Inc.
181 Grand Avenue, Suite 225
Southlake, TX 76092 / US
[2022/39]
Inventor(s)01 / ZHAO, Tian
181 Grand Ave, Ste 225
Southlake, Texas 76092 / US
02 / JAYALAKSHMI, Yalia
181 Grand Ave, Ste 225
Southlake, Texas 76092 / US
03 / HALL, Keith A.
181 Grand Ave, Ste 225
Southlake, Texas 76092 / US
04 / MADAJEWSKI, Brian
181 Grand Ave, Ste 225
Southlake, Texas 76092 / US
05 / KAPLAN, Hargita
181 Grand Ave, Ste 225
Southlake, Texas 76092 / US
 [2022/39]
Representative(s)Smart, Jessica Ann, et al
Kilburn & Strode LLP
Lacon London
84 Theobalds Road
London WC1X 8NL / GB
[2022/39]
Application number, filing date20888772.917.11.2020
[2022/39]
WO2020US60910
Priority number, dateUS201962937141P18.11.2019         Original published format: US 201962937141 P
[2022/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021101905
Date:27.05.2021
Language:EN
[2021/21]
Type: A1 Application with search report 
No.:EP4061428
Date:28.09.2022
Language:EN
The application published by WIPO in one of the EPO official languages on 27.05.2021 takes the place of the publication of the European patent application.
[2022/39]
Search report(s)International search report - published on:US27.05.2021
(Supplementary) European search report - dispatched on:EP21.11.2023
ClassificationIPC:A61K49/00, G01N33/50, G01N33/58, C07C69/54, C08F293/00
[2023/51]
CPC:
G01N33/84 (EP,IL,KR,US); C08F220/34 (KR); A61K49/0054 (EP,IL,KR,US);
A61K49/0032 (EP,IL,KR); A61K49/0082 (KR,US); C07D209/42 (EP);
C08F220/382 (KR); C08F293/005 (EP); C08F299/00 (KR);
G01N33/582 (EP,US); C08F2438/01 (EP); G01N2800/7028 (EP,IL,KR,US) (-)
Former IPC [2022/39]A61K49/00, G01N33/50
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/39]
TitleGerman:AUF PH-ANSPRECHENDE ZUSAMMENSETZUNGEN, FORMULIERUNGEN UND VERFAHREN ZUR ABBILDUNG EINES TUMORS[2022/39]
English:PH RESPONSIVE COMPOSITIONS, FORMULATIONS, AND METHODS OF IMAGING A TUMOR[2022/39]
French:COMPOSITIONS SENSIBLES AU PH, FORMULATIONS ET MÉTHODES POUR IMAGER UNE TUMEUR[2022/39]
Entry into regional phase16.05.2022National basic fee paid 
16.05.2022Search fee paid 
16.05.2022Designation fee(s) paid 
16.05.2022Examination fee paid 
Examination procedure16.05.2022Examination requested  [2022/39]
07.06.2024Amendment by applicant (claims and/or description)
07.06.2024Date on which the examining division has become responsible
Fees paidRenewal fee
18.11.2022Renewal fee patent year 03
09.11.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US2017143852  (GAO JINMING [US], et al) [X] 1-15 * Figs. 1, 15, 76A *;
 [A]WO2019094906  (UNIV TEXAS [US]) [A] 1-5 * p.17, formula (I) *;
 [E]WO2020243217  (UNIV TEXAS [US]) [E] 1-15* the whole document *;
 [YP]  - BENNETT ZACHARY T. ET AL, "Detection of Lymph Node Metastases by Ultra-pH-Sensitive Polymeric Nanoparticles", THERANOSTICS, AU, (20200101), vol. 10, no. 7, doi:10.7150/thno.41239, ISSN 1838-7640, pages 3340 - 3350, XP093059770 [YP] 1-15 * Fig. 1 *

DOI:   http://dx.doi.org/10.7150/thno.41239
 [Y]  - ZHEN LI ET AL, "Ultra-pH-sensitive indocyanine green-conjugated nanoprobes for fluorescence imaging-guided photothermal cancer therapy", NANOMEDICINE: NANOTECHNOLOGY, BIOLOGY, AND MEDICINE, AMSTERDAM, NL, (20190401), vol. 17, doi:10.1016/j.nano.2019.02.001, ISSN 1549-9634, pages 287 - 296, XP055763757 [Y] 1-15 * abstract; p. 288,col.2, par. 3; p. 290, col.1, par. 3; fig. 1b, p.292, col.1, par. 1-col.2 *

DOI:   http://dx.doi.org/10.1016/j.nano.2019.02.001
 [Y]  - LUO MIN ET AL, "A STING-activating nanovaccine for cancer immunotherapy", NATURE NANOTECHNOLOGY, London, vol. 12, no. 7, doi:10.1038/nnano.2017.52, ISSN 1748-3387, (20170701), pages 648 - 654, URL: https://www.nature.com/articles/nnano.2017.52.pdf, XP055916800 [Y] 1-15 * abstract; suppl. fig. 1 *

DOI:   http://dx.doi.org/10.1038/nnano.2017.52
 [A]  - XINPENG MA ET AL, "Ultra-pH-Sensitive Nanoprobe Library with Broad pH Tunability and Fluorescence Emissions", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, (20140729), vol. 136, no. 31, doi:10.1021/ja5053158, ISSN 0002-7863, pages 11085 - 11092, XP055427451 [A] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1021/ja5053158
International search[A]US2013131354  (LANGHALS HEINZ [DE], et al) [A] 1-3, 23-27 and 40 * entire dpcument *;
 [A]US2017049911  (GAO JINMING [US], et al) [A] 1-3, 23-27 and 40 * entire document *;
 [A]US2017143852  (GAO JINMING [US], et al) [A] 1-3, 23-27 and 40 * entire documet especailly figure 1, figure 15 A&B and figure 76A . *;
 [A]WO2019094906  (UNIV TEXAS [US]) [A] 1-3, 23-27 and 40 * entire document especially page 41 formula *;
 [EX]WO2020243217  (UNIV TEXAS [US]) [EX] 1-3, 23-27 and 40* entire document especially claims 1-26 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.